Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

See Release

All News

Archives

Endologix LLC Receives FDA Breakthrough Device Designation for ChEVASTM System

Endologix LLC Announces Launch of ALTO® Abdominal Stent Graft System in Canada and Argentina Company Expands Global Reach with Latest Endovascular Aneurysm Repair (EVAR) Technology

Endologix LLC Announces Acquisition of PQ Bypass, Inc.

Endologix Launches ALTO™ Abdominal Stent Graft System in Europe

Endologix Announces First Commercial Implant of ALTO Abdominal Stent Graft System Outside of United States